Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin in Metastatic Breast Cancer
NCT00006121Phase 2Terminated
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- May 2000
- Primary completion
- May 2002
- Modality
- DNA Intercalators/Alkylators
- Countries
- 7
01
Overview
A Phase 2 trial of oxaliplatin in breast cancer, sponsored by European Organisation for Research and Treatment of Cancer. Started May 2000; status: terminated.
02
Drugs
oxaliplatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00006121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006121.